{"url_path":"/sec/imux/8-k/2026-05-19/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-19","source_url":"https://www.sec.gov/Archives/edgar/data/1280776/0001193805-26-000645-index.html","accession_number":"0001193805-26-000645","cik":"0001280776","ticker":"IMUX","issuer_name":"IMMUNIC, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1280776/0001193805-26-000645-index.html","primary_entity_key":"0001280776","primary_entity_name":"IMMUNIC, INC."},"word_count":145,"has_tables":true,"body_markdown":"Item 7.01 Regulation FD Disclosure.\n\n** **\n\nOn May 19, 2026, the\nCompany issued a press release announcing the appointment of Mr. Bonney as Chair of the Board. A copy of the press release is\nfurnished as Exhibit 99.1 hereto and is incorporated herein by reference. The information set forth in this Item 7.01 and in Exhibit\n99.1 is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as\namended (the “Exchange Act”), or otherwise subject to the liabilities of that Section. The information in this Item 7.01\nand in Exhibit 99.1 shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act, or\nthe Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in such\na filing."}